Want to create an interactive transcript for this episode?
Podcast: CME
Episode: Emerging Clinical Evidence for B7-H3–Directed ADCs in ES-SCLC From WCLC 2025
Description:
Faculty: Luis Paz-Ares, MD, PhD
Faculty: Lauren A. Byers, MD
This online CME program will provide the latest clinical updates on B7-H3–directed antibody-drug conjugates (ADCs) in extensive-stage small cell lung cancer (ES-SCLC). Faculty experts will review the biological rationale for targeting B7-H3 in ES-SCLC and discuss recent clinical evidence on B7-H3 ADCs presented at WCLC and ESMO 2025. Participants will gain practical insights on selecting appropriate patients for B7-H3 ADCs, including efficacy and safety considerations. The program will equip oncology professionals with evidence-based strategies to integrate emerging B7-H3 ADCs into multidisciplinary care fo...